Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 6Colorectal Neoplasms 3Stomach Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Skin Neoplasms 1Sezary Syndrome 1Retroviridae Infections 1Recurrence 1Prostatic Neoplasms 1Pancreatic cancer, adult 1Ovarian Neoplasms 1Mycosis Fungoides 1Malnutrition 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Glioblastoma 1Esophageal Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Barrett Esophagus 1

Interventions

Cyclophosphamide 21venetoclax 18pembrolizumab 16Dexamethasone 16fludarabine 14Cytarabine 13Gemcitabine 9pomalidomide 8Rituximab 8Carboplatin 8Azacitidine 8glofitamab 7fludarabine phosphate 7Lenalidomide 7Immunotherapy, Adoptive 7selinexor 6Paclitaxel 6Injections 6Granulocyte Colony-Stimulating Factor 6Cisplatin 6daratumumab 5Temozolomide 5Oxaliplatin 5Bevacizumab 5zanubrutinib 4ruxolitinib 4Surgical Procedures, Operative 4Nivolumab 4Drug Therapy 4Decitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Recurrence × Hematologic Tests × Clear all
NCT04740346 2021-10-27

Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)

National Cancer Center, Korea

Phase NA Recruiting
886 enrolled
Gastrointestinal

Recurrence, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡